Optimi Health Corp.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
68405H100
SEDOL
N/A
CIK
N/A
www.optimihealth.ca
LEI:
©
New: Infographics X-Lab
FIGI: BBG00ZF25693
OPTHF
Optimi Health Corp.
GICS: - · Sektor: Consumer Defensive · Sub-Sektor: Farm Products
AI
PROFILER
NAME
Optimi Health Corp.
ISIN
CA68405H1001
TICKER
OPTHF
MIC
XOTC
REUTERS
OPTHF.PK
BLOOMBERG
OPTHF US
F&G: 30
1,38674 USDCAD · 93.662,71 BTC · 24,10 Vola-Index · 19.334,60 Tech100
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von Newsfile Corp. bereitgestellt.
Mi., 12.03.2025       Optimi Health
CA68405H1001

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-compliant, Health Canada-licensed manufacturer specializing in botanical psilocybin and MDMA, is pleased to provide the following corporate update, highlighting key regulatory milestones, clin...
Zur Nachricht
Optimi Health
Technische Analyse Termsheet Terminal
Permalink
Mi., 29.01.2025       Optimi Health
CA68405H1001

Over 4,000 GMP Capsules Ready to Support PTSD Treatment in Australia, Israel, and CanadaVancouver, British Columbia--(Newsfile Corp. - January 29, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian-based company licensed by Health Canada to produce and supply natural, GMP-grade psilocybin and M...
Zur Nachricht
Optimi Health
Technische Analyse Termsheet Terminal
Permalink
Mi., 29.01.2025       Optimi Health
CA68405H1001

Vancouver, British Columbia--(Newsfile Corp. - January 28, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psychedelics pharmaceutical manufacturer specializing in botanical psilocybin and MDMA, announces it has closed the second and final tranche (the "Second Tra...
Zur Nachricht
Optimi Health
Technische Analyse Termsheet Terminal
Permalink
Fr., 17.01.2025       Optimi Health
CA68405H1001

Non-Brokered Private Placement and Debt SettlementVancouver, British Columbia--(Newsfile Corp. - January 17, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psychedelics pharmaceutical manufacturer specializing in botanical psilocybin and MDMA, announces it intend...
Zur Nachricht
Optimi Health
Technische Analyse Termsheet Terminal
Permalink
Mo., 13.01.2025       Optimi Health
CA68405H1001

The Company's natural psilocybin extract powers a culturally transformative study to address methamphetamine addiction through indigenous frameworks.Vancouver, British Columbia--(Newsfile Corp. - January 13, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psyche...
Zur Nachricht
Optimi Health
Technische Analyse Termsheet Terminal
Permalink
Mo., 06.01.2025       Optimi Health
CA68405H1001

Vancouver, British Columbia--(Newsfile Corp. - January 6, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic pharmaceuticals specializing in natural psilocybin and MDMA, is pleased to announce the completion of its second shipment of GMP-certified MDMA ...
Zur Nachricht
Optimi Health
Technische Analyse Termsheet Terminal
Permalink
Di., 17.12.2024       Optimi Health
CA68405H1001

Agreement Supports Phase IIb and Future Phase III Trial Development,Addressing Critical Needs in Palliative Care Using Optimi's Natural Psilocybin ExtractVancouver, British Columbia--(Newsfile Corp. - December 17, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian manufacturer of GMP-certified,...
Zur Nachricht
Optimi Health
Technische Analyse Termsheet Terminal
Permalink
Mi., 23.10.2024       Optimi Health
CA68405H1001

Additional 700 Doses Ordered by Mind Medicine Australia as Demand SurgesVancouver, British Columbia--(Newsfile Corp. - October 23, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic pharmaceuticals specializing in botanical psilocybin and MDMA, is proud...
Zur Nachricht
Optimi Health
Technische Analyse Termsheet Terminal
Permalink
Mo., 21.10.2024       Optimi Health
CA68405H1001

Vancouver, British Columbia--(Newsfile Corp. - October 21, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-compliant, Health Canada-licensed manufacturer of psychedelics specializing in botanical psilocybin and MDMA, today announced that Mr. William (Bill) Ciprick will be stepping down as Chief E...
Zur Nachricht
Optimi Health
Technische Analyse Termsheet Terminal
Permalink
Mi., 28.08.2024       Optimi Health
CA68405H1001

Trial to study Major Depressive Disorder using Optimi's GMP natural psilocybin capsules in conjunction with therapyVancouver, British Columbia--(Newsfile Corp. - August 28, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-compliant, Health Canada-licensed manufacturer of psychedelics pharmaceutica...
Zur Nachricht
Optimi Health
Technische Analyse Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S